- Home
- HAVA vs GALT Comparison
HAVA vs GALT Comparison
Compare HAVA & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$2.83
Company Overview
Basic Information| Metric | HAVA | GALT |
|---|---|---|
| Founded | 2024 | 2000 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.6M | 199.2M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | HAVA | GALT |
|---|---|---|
| Price | $10.09 | $2.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 569.0 | ★ 302.4K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.90 | $2.03 |
| 52 Week High | $10.11 | $7.13 |
Technical Indicators
Market Signals| Indicator | HAVA | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 63.31 | 64.06 |
| Support Level | $10.03 | $2.62 |
| Resistance Level | N/A | $3.36 |
| Average True Range (ATR) | 0.00 | 0.18 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 74.97 | 84.44 |
Price Performance
Historical Comparison HAVA
GALT
About HAVA Harvard Ave Acquisition Corporation Class A Ordinary Share
Harvard Ave Acquisition Corp is a blank check company.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.